S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

GALT Galectin Therapeutics Inc

2.54

0.04 (1.60%)

Last Updated: 06:08:16

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Galectin Therapeutics Charts.

Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Galectin Therapeutics Charts.

Galectin Therapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 24 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 18 October 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 17 October 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Saturday 5 October 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 9 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 26 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 13 August 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 13 August 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 5 August 2024 (3 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Monday 5 August 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 1 August 2024 (3 months ago) • Edgar (US Regulatory)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Tuesday 23 July 2024 (3 months ago) • Edgar (US Regulatory)

More Galectin Therapeutics Inc News Articles

Eloxx Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions